Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us


Drug and Gene Delivery Systems Market: North America Expected to Remain at the Forefront in Terms of Innovation

Press release Description

Albany, New York, May 30, 2018: The global drug and gene delivery systems market is likely to grow at over 6% CAGR through 2025, on account of increasing emphasis on offering advanced drugs. The rising prevalence of chronic diseases is anticipated to provide lucrative growth opportunities for manufacturers during the assessment period. These insights are according to a new research study added to the vast repository of Market Research Reports Search Engine (MRRSE).

The business intelligence study offers in-depth analysis and insights on the key factors that are driving and hindering the growth of the market. According to the report, emergence of new and advanced technologies, and growing demand for low dosing frequency are some of the leading factors for the growth of the market. The growing pervasiveness of home healthcare services, combined with a tendency of patients to self-administer is also likely to provide an impetus to growth during the assessment period.

Highlighting the key impediments in the market, the report opines that drug and gene delivery systems market can be negatively influenced by increasing costs and rise in the total number of drug recalls. Difficulties in gaining regulatory approval can also challenge the prospects of key players in this market.

According to the research study, North America and Europe continue to be the leading markets for drug and gene delivery systems around the globe. The market in North America is likely to remain concentrated in the US, whereas the key players in the market are focusing on boosting their presence in Western Europe. These factors are likely to provide an impetus to growth during the assessment period.

In a bid to give readers detailed insights on the drug and gene delivery systems market, the research study offers in-depth segment-wise analysis. The report has segmented the market on the basis of delivery system, application, and route of administration. The key segments on the basis of delivery system include drug delivery and gene delivery. In the drug delivery segment, targeted drug delivery sub-segment is likely to account for a leading share of the market. According to the report, targeted drug delivery segment is likely to grow at a brisk pace during the assessment period.

The research study also offers detailed insights on the key players operating in the drug and gene delivery systems market. Some of the leading players in the market include Epeius Biotechnologies Corporation, Boston Scientific Corporation, Human Stem Cells Institute, Baxter International, Inc., and AstraZeneca plc.

Browse Full Global Drug and Gene Delivery Systems Market Report with TOC :

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.


State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States

Telephone: +1-518-730-0559